Baudax Bio, Inc.

  • Home
  • About
    • Overview
    • Management Team
    • Board of Directors
  • R&D
    • Product Portfolio
    • ANJESO® (meloxicam) injection
    • NMB & Reversal Agent
    • Investigator Sponsored Research
  • Therapeutic Areas
    • Post-Operative Pain
    • Anesthesia
  • News & Investors
    • Overview
    • Press Releases
    • Events
    • Presentations
    • Governance
    • Stock Info
    • Financial & Filings
  • Contact
  • Careers

Press Releases

News & Investors

News & Investors

  • Overview
  • Press Releases
  • Events
  • Presentations
  • Governance
    • Governance Documents
    • Board of Directors
    • Board Committees
  • Stock Info
    • Form 8937
  • Financial & Filings
    • Overview
    • All SEC Filings

Baudax Bio Strengthens Management Team with Appointment of Richard S. Casten as Chief Financial Officer

Mar 08, 2021 7:00am EST

Baudax Bio to Present at the H.C. Wainwright Global Life Sciences Conference

Mar 02, 2021 7:00am EST

Baudax Bio Reports 2020 Annual Financial Results

Feb 16, 2021 7:00am EST

Baudax Bio to Report 2020 Annual Financial Results and Host Conference Call and Webcast on February 16, 2021

Feb 10, 2021 8:04am EST

Baudax Bio Announces $17.6 Million Offering Priced At-the-Market under Nasdaq Rules

Feb 08, 2021 3:24pm EST

Baudax Bio Announces Exercise of Warrants for Gross Proceeds of $13.4 Million

Jan 21, 2021 9:28am EST

Baudax Bio to Present at the H.C. Wainwright BioConnect 2021 Conference

Jan 06, 2021 7:00am EST

Baudax Bio Announces $12 Million Offering Priced at a Premium to Market

Dec 17, 2020 7:00am EST

Baudax Bio to Participate in the Piper Sandler 32nd Annual Healthcare Conference

Nov 30, 2020 4:05pm EST

Baudax Bio Announces $12 Million Offering Priced at a Premium to Market

Nov 23, 2020 8:00am EST
RSS
  • Prev
    • 1...
    • 2
    • 3
    • 4
    • 5
    • 6
    • 7
    • 8
    • 9
    • 10
    • 11
    Next
    • Email Alerts
    • Tear Sheet
    • RSS News Feed
    © 2023 Baudax Bio, Inc. All Rights Reserved. ANJESO is a registered trademark of Baudax Bio, Inc.
    Privacy Policy Terms of Use Disclaimer Sitemap